SHEFA Medical
SHEFA Medical
The global pharmaceutical landscape is undergoing a systemic paradigm shift toward non-invasive systemic and targeted pulmonary delivery mechanisms. As chronic respiratory disorders such as COPD, asthma, cystic fibrosis, and various infectious diseases continue to rise globally, the requirements for aerosolized administration formats have mutated from standard, basic therapies to complex, highly tailored engineering challenges.
Custom OEM Inhalation Therapies represent the critical junction between polymer chemistry, precision fluid dynamics, and clinical user compliance. Delivering dry powders (DPIs), metered doses (pMDIs), and nebulized formulations requires micro-scale design tolerance. For developers, partnering with a qualified OEM supplier is no longer a matter of outsourcing simple injection-molded parts; it is an absolute technical integration that influences the therapeutic efficacy of the drug formulation.
Transitioning medical devices to comply with new regulations like EU MDR (Regulation EU 2017/745) requires comprehensive documentation, biocompatibility testing (ISO 10993), and rigorous technical files that ensure reliable, audit-ready performance.
Mitigating critical operational risks through continuous raw material supplier audits, strategic safety stock management, and highly optimized tooling programs designed to prevent costly single-point-of-failure bottlenecks.
Managing target aerosol flows and dynamic air resistance through precise component tooling. We build customized airflow chambers designed to minimize physical powder retention and maximize fine particle delivery to the lungs.
Inhalation drug products require custom device parameters. Nebulizer drug solutions, dry powder formulations, and metered suspensions react differently to static charge, humidity, and shear forces. By engaging in deep design-for-manufacturing (DFM) support, our engineering team works closely with pharmaceutical manufacturers to match specific aerosol velocities and chemical characteristics with high-performance physical structures. This holistic validation reduces regulatory approval cycle times and stabilizes downstream manufacturing steps.
Weihai SHEFA Medical Technology Co., Ltd. is a specialized, professional medical products designer, manufacturer, and exporter based in China. Since our initial founding, we have consistently operated under the core principles of "Quality First and Reputation Supreme". This foundational philosophy continues to guide all of our product development, production processes, and worldwide distribution networks.
Today, SHEFA Medical is recognized as an industry-leading partner offering medical products across Class I, Class II, and Class III designations. Our broad range of surgical dressings, medical disposable accessories, and specialized device systems are manufactured to support clinicians in critical situations daily.
Recognizing that surgical dressings and medical devices are essential cornerstones of global healthcare systems, we have established robust, scalable manufacturing bases across multiple provinces in China. These modern facilities run automated lines, integrated cleanroom operations, and strict quality control stations to maintain high-capacity, zero-defect output for our global partners.
Our comprehensive production and engineering capabilities cover a diverse product scope, supporting global OEM medical needs across departments:
To systematically standardize our global operations and confidently satisfy the requirements of international partners, SHEFA Medical maintains a fully audited quality system. We have successfully secured key certifications that confirm our alignment with rigorous international health and safety guidelines:
Currently, SHEFA Medical products are distributed and trusted by partners in over 20 countries across the Middle East, Africa, South America, Europe, and Asia. Our professional technical group, strict quality control procedures, and customer-first service help ensure we remain a reliable, long-term OEM supplier.
Our custom OEM inhalation therapy workflow is built around a structured development phase: from 3D modeling and computational fluid dynamics (CFD) simulation of airflows, to rapid steel-mold fabrication and validation in sterile environments. We support target device configurations including customized aerosol paths, proprietary actuator designs, and customized color profiles. Each component undergoes extensive testing to confirm uniform, reliable dosing and long-term durability in real-world clinical environments.
Integrating mechanical inhalation devices with electronic sensors to monitor patient adherence, calculate peak inspiratory flow, and transmit secure usage records back to primary clinical caregivers.
Co-developing specialized valve systems and robust canister seals compatible with green, low-GWP (Global Warming Potential) propellants like HFA-152a and HFO-1234ze.
Innovating vibrating mesh nebulizers and microfluidic technologies to generate ultra-fine, uniform droplets that help prevent biological protein shear degradation.
